A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy

By sjmartinez • November 20, 2024

Patel N, Karanth R, Isaacs DJ, Cohen J, Wong DJ, Delshad SD. A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy. Cureus. 2024 Oct 19;16(10):e71867. doi: 10.7759/cureus.71867. PMID: 39559603; PMCID: PMC11573227.

Tags: cancer immunotherapy, Cetuximab, General Internal Medicine, hematology-oncology, Hematology/Oncology, Hospitalist, immune-related adverse event, irae, pembrolizumab side effect, posterior reversible encephalopathy syndrome, pres, Publications

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring

Alkabbani W, Cromer SJ, Patorno E. Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring. Diabetes Care. 2026 Sep 1;49(9):1554-1556. doi: 10.2337/dci26-0084.[...]